Financial Information and Business Update
To present in vivo data with odiparcil at the 14th WORLDSymposium™
Inventiva Announces Positive DSMB Review in Phase IIb FASST Trial in Systemic Sclerosis with Lanifibranor
ANNOUNCES ENROLLMENT OF FIRST PATIENT INTO ITS ODIPARCIL PHASE IIA TRIAL (IMPROVES) FOR MPS VI
For their large attendance during the 2017 edition of Salon Actionaria
KOL meeting and webcast on Odiparcil, our novel treatment for MPS VI patientsNew-York, Thursday, November 30, 2017, 8:00-9:30 am EST
Lanifibranor: Phase IIb trial in NASH, recruiting now
Lanifibranor: Phase IIb trial in Systemic Sclerosis.
Odiparcil: Phase IIa in MPSVI, in preparation. Recruiting now
No front page content has been created yet.